Actively Recruiting

Age: 18Years +
All Genders
NCT07274072

Hospital at Home Versus Inpatient Care: Costs and Effectiveness

Led by Hospital at Home AG · Updated on 2025-12-10

200

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

Sponsors

H

Hospital at Home AG

Lead Sponsor

K

Klinik Hirslanden, Zurich

Collaborating Sponsor

AI-Summary

What this Trial Is About

Background and Objectives Hospital at Home (HaH) delivers hospital-level treatment to acutely ill patients in their own homes, including daily medical and nursing visits, infusions, physiotherapy, and diagnostics. It bridges inpatient and outpatient care, working closely with hospitals, office-based physicians, home care services (Spitex), and therapy providers. There are two main pathways: Admission Avoidance: stable patients requiring hospitalization are admitted directly to HaH instead of an inpatient ward. Early Supported Discharge: patients treated in hospital are discharged earlier than usual and transferred to HaH. Evidence International studies show HaH to be safe and effective. Reviews report comparable mortality and rehospitalization, shorter hospital stays, and cost advantages. Admission avoidance is linked to trends toward lower mortality and costs. Research showed similar mortality but fewer rehospitalizations, longer treatment duration, and reduced risks of institutionalization, depression, and anxiety. HaH patients were older, with reduced daily living activities, yet care costs were on average USD 5,054 lower than inpatient care. In Switzerland, the mean hospital stay in 2019 was 8 days (acute somatic: 5.2; psychiatry: 33.5). Study Hypotheses HaH can be delivered at equal or lower cost than regular hospitalization. HaH care is safe, with few complications, and yields high patient satisfaction. Study Objective To demonstrate that hospital-equivalent home treatment of acutely ill patients is effective, appropriate, cost-efficient (according to Swiss WZW criteria), safe, and associated with high satisfaction and low complication rates compared with inpatient care. Endpoints Primary: Costs - HaH vs. inpatient care at Hirslanden Clinic, using REKOLE® cost accounting. Secondary: Mortality, therapy type, monitoring, diagnostics, rehospitalization, complications, satisfaction, patient-reported outcomes, length of stay, referrals to nursing homes, follow-up after discharge, ED visits, rehabilitation referrals, and home care type.

CONDITIONS

Official Title

Hospital at Home Versus Inpatient Care: Costs and Effectiveness

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Inpatients in the hospital or patients in Hospital at Home care
  • Age 18 years or older
  • Admission due to a typical Hospital at Home diagnosis such as mild to moderate inflammatory and infectious diseases of the lungs, urinary tract, gastrointestinal tract, heart, and skin; exacerbated chronic obstructive pulmonary disease; exacerbation of chronic heart failure; wounds; bleeding or anemia; dehydration; deterioration of general condition in multimorbid patients; infection-related complications in oncology patients; psychiatric problems including delirium; metabolic or autoimmune diseases; orthopedic patients; pain exacerbations of any cause; palliative patients up to and including terminal situations
  • Patients without severe cognitive impairment or dysfunction capable of providing informed consent and/or completing questionnaires
  • Patients with sufficient proficiency in written and spoken German and/or English
Not Eligible

You will not qualify if you...

  • Inpatient admission for reasons other than typical Hospital at Home diagnoses
  • Refusal to provide informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hospital at Home AG

Zollikon, Canton of Zurich, Switzerland, 8702

Actively Recruiting

Loading map...

Research Team

K

Kilian Braendle, Dr. med.

CONTACT

N

Natascha Furrer, Coordinator

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here